General Information of the Compound
| Compound ID |
CP0423445
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
EDROPHONIUM BROMIDE
Show/Hide
|
||||||||||||||||||
| Synonyms |
(3-hydroxyphenyl)dimethylethylammonium
3-hydroxy-N,N-dimethyl-N-ethylanilinium
EDR
EDROPHONIUM ION
ENLON-PLUS
Edrophone Chloride
Edrophonium
Edrophonum
Edroponium
Enlon (TN)
Enlon Plus
Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium
Ethyl-(3-hydroxyphenyl)-dimethylazanium
N-ethyl-3-hydroxy-N,N-dimethylanilinium
N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium
Reversol
Reversol (TN)
Tensilon
Tensilon (TN)
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H16NO+
|
||||||||||||||||||
| Molecular Weight |
166.244
|
||||||||||||||||||
| Canonical SMILES |
CC[N+](C)(C)c1cccc(O)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VWLHWLSRQJQWRG-UHFFFAOYSA-O
|
||||||||||||||||||
| CAS |
312-48-1
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound